XNYS
HR
Market cap5.92bUSD
Oct 08, Last price
17.19USD
1D
1.84%
1Q
-16.92%
Jan 2017
-43.30%
Name
Healthcare Realty Trust Inc (Tennessee)
Chart & performance
P/E
—
P/S
—
EPS
—
Div yield, %
6.52%
Shrs. gr., 5y
9.55%
Rev. gr., 5y
9.94%
Revenues
1.18b
-6.92%
Net income
-246m
L-62.40%
CFO
457m
-8.88%
Dividend
Aug 11, 20260.24 USD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Healthcare Realty Trust operates as a Real Estate Investment Trust (REIT), specializing in the acquisition, development, financing, and active management of income-generating real estate assets, predominantly serving outpatient healthcare providers throughout the United States. By September 30, 2020, its extensive portfolio comprised 211 properties located across 24 states, collectively spanning 15.5 million square feet and valued at approximately $5.5 billion. The company further provided comprehensive leasing and property management solutions for 11.9 million square feet nationwide.
Key people
John Singleton
Independent Chairman of the Board · since 2019
J. Christopher Douglas
Chief Financial Officer, Executive Vice President · since 2016
Robert Hull
Executive Vice President - Investments · since 2017
Julie Wilson
Executive Vice President - Operations · since 2021
John Bryant
Executive Vice President, General Counsel · since 2003
Todd Meredith
President, Chief Executive Officer, Director · since 2017
John Abbott
Independent Director · since 2019
Independent Director · since 2016
Independent Director · since 2018
Ajay Gupta
Independent Director · since 2021
James Kilroy
Independent Director · since 2021
Peter Lyle
Independent Director · since 2016
Christann Vasquez
Independent Director · since 2015
Legal address
C/O CSC-LAWYERS INCORPORATING SERVICE COMPANY
7 ST. PAUL STREET
SUITE 820
BALTIMORE, MD 21202
US
7 ST. PAUL STREET
SUITE 820
BALTIMORE, MD 21202
US
Headquarters
3310 West End Avenue
Suite 700
Nashville, TN 37203
US
Suite 700
Nashville, TN 37203
US
Valuation
Title in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT |